These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 16652347

  • 1. The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.
    Riemenschneider M, Blennow K, Wagenpfeil S, Andreasen N, Prince JA, Laws SM, Förstl H, Kurz A.
    Hum Mutat; 2006 Jun; 27(6):532-7. PubMed ID: 16652347
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
    Kester MI, van der Vlies AE, Blankenstein MA, Pijnenburg YA, van Elk EJ, Scheltens P, van der Flier WM.
    Neurology; 2009 Oct 27; 73(17):1353-8. PubMed ID: 19858456
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42).
    Kaiser E, Schönknecht P, Thomann PA, Hunt A, Schröder J.
    Neurosci Lett; 2007 May 01; 417(2):193-5. PubMed ID: 17408854
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.
    Biol Psychiatry; 2008 Nov 15; 64(10):850-5. PubMed ID: 18395699
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    van der Vlies AE, Verwey NA, Bouwman FH, Blankenstein MA, Klein M, Scheltens P, van der Flier WM.
    Neurology; 2009 Mar 24; 72(12):1056-61. PubMed ID: 19307538
    [Abstract] [Full Text] [Related]

  • 17. Genetic polymorphism in exon 2 of cathepsin D is not associated with vascular dementia.
    Jeong BH, Lee KH, Lee YJ, Yun J, Park YJ, Kim YH, Cho YS, Choi EK, Carp RI, Kim YS.
    Acta Neurol Scand; 2011 Jun 24; 123(6):419-23. PubMed ID: 20597865
    [Abstract] [Full Text] [Related]

  • 18. Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
    Gerhardsson L, Blennow K, Lundh T, Londos E, Minthon L.
    Dement Geriatr Cogn Disord; 2009 Jun 24; 28(1):88-94. PubMed ID: 19672066
    [Abstract] [Full Text] [Related]

  • 19. Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population.
    Payton A, van den Boogerd E, Davidson Y, Gibbons L, Ollier W, Rabbitt P, Worthington J, Horan M, Pendleton N.
    Genes Brain Behav; 2006 Jun 24; 5 Suppl 1():23-31. PubMed ID: 16417614
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal stability of CSF biomarkers in Alzheimer's disease.
    Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, Basun H, Andreasen N.
    Neurosci Lett; 2007 May 23; 419(1):18-22. PubMed ID: 17482358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.